Haemophilia Treatment Market, By Type (Haemophilia A, Haemophilia B), By Treatment (Prophylaxis, On Demand), By End Use (Hospitals, Clinics, Haemophilia Treatment Centers), By Drug Therapy (Recombinant coagulation factor concentrates therapy, Plasma derived coagulation factor concentrates therapy, Non-factor replacement therapy, Others), By Country, and By Region Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Haemophilia Treatment Market size was valued at USD 12,908.9 Million in 2022, expanding at a CAGR of 8.2% from 2023 to 2030.
Market Dynamics
Haemophilia Treatment market is expected to witness substantial growth over the forecasted period. Throughout the projection period, new product launches by market participants in the haemophilia treatment are anticipated to boost the market growth. For instance, the European Commission granted Novo Nordisk permission to market "Esperoct" in Europe in June 2019. Turoctocog alfa pegol, N8-GP, is marketed under Esperoct and used for surgical procedures in adolescents and adults with haemophilia A. (congenital factor VIII deficiency). Additionally, in April 2019, Roche Products India Pvt. Ltd. introduced the Hemlibra brand of Emicizumab, a medication for haemophilia A. Factor VIII inhibitors are approved for preventative treatment to decrease the frequency of bleeding incidences in people with haemophilia A.
Additionally, it is anticipated that rising government initiatives to raise public awareness of haemophilia treatment will fuel market expansion throughout the projection period. For instance, the Australian Haemophilia Center Directors' Organization (AHCDO) receives funding from the National Bleeding Authority (NBA) for the care and treatment of haemophilia A (Factor VIII Deficiency) in Australia. The increasing prevalence of haemophilia and other bleeding diseases is predicted to increase the market for haemophilia treatments worldwide significantly. For instance, the Australian Bleeding Disorders Registry estimates that in 2015, there were approximately 4,941 people in Australia who had one of the prevalent inherited bleeding disorders, of whom 2,301 had haemophilia A, and 548 had haemophilia B.
Regional Insights
North America is estimated to dominate this global market. A number of factors, including increased government investment on healthcare and R&D initiatives as well as the existence of reputable manufacturers, are responsible for the nation's rapid rise. The business revenue is also being boosted by rising target patient populations and rising knowledge of technologically advanced items. According to the World Federation of Haemophilia (WFH), around 17,757 Americans had a haemophilia diagnosis in 2018. Haemophilia Federation of America (HFA) is an organisation that frequently offers patients ongoing care by promoting various co-pay initiatives. Due to the expansion of favourable reimbursement policies for haemophilia treatment in countries like China, the Asia Pacific is anticipated to see the second-largest increase in the global market for haemophilia treatment.
Segment Dynamics
The Haemophilia Treatment market is fragmented into the disease, treatment, and end-user segments. Based on the disease, the Haemophilia A segment is anticipated to dominate the market. By treatment, the prophylaxis segment is projected to grow at highest rate (CAGR) during the forecast period. By end-user, the hospitals market segment is expected to hold the major portion of the market.
Competitive Insights
The Haemophilia Treatment market is competitive in nature with the presence of local & international players. Major players in the industry engage in strategic merger & acquisition, partnership, and new product launches to remain competent in the market. For example, in June 2022, FDA granted efanesoctocog alfa Breakthrough Therapy designation for haemophilia A. In May 2022,
Takeda Pharmaceutical launched Adynovate (brand name) an extended half-life recombinant Factor VIII (rFVIII) treatment using established technology (controlled PEGylation) for haemophilia A patients. Takeda is a global values-based, R&D-driven biopharmaceutical leader having an innovative rare diseases portfolio in India.
Key features of the study:
- This proposed research study on Haemophilia Treatment market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
- The report provides the client the latest up-to-date and trending insights about the Haemophilia Treatment market.
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Haemophilia Treatment market
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Haemophilia Treatment market
- Impact of COVID-19 on Haemophilia Treatment market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Haemophilia Treatment market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the Haemophilia Treatment market, we have also included competitive landscape and key innovator analysis for the Haemophilia Treatment market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
- The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Haemophilia Treatment market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
- The global Haemophilia Treatment market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HAEMOPHILIA TREATMENT MARKET KEY PLAYERS
- Bayer Healthcare
- Biogen
- Biotest AG
- CSL Behring
- Ferring B.V.
- Genentech
- Kedrion
- Novo Nordisk
- Octapharma
GLOBAL HAEMOPHILIA TREATMENT MARKET, BY TYPE
- Haemophilia A
- Haemophilia B
GLOBAL HAEMOPHILIA TREATMENT MARKET, BY TREATMENT
- Prophylaxis
- On Demand
GLOBAL HAEMOPHILIA TREATMENT MARKET, BY END USE
- Hospitals
- Clinics
- Haemophilia Treatment Centers
GLOBAL HAEMOPHILIA TREATMENT MARKET, BY DRUG THERAPY
- Recombinant coagulation factor concentrates therapy
- Plasma derived coagulation factor concentrates therapy
- Non-factor replacement therapy
- Others
GLOBAL HAEMOPHILIA TREATMENT MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Haemophilia Treatment Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Haemophilia Treatment Market Snippet by Type
2.1.2. Haemophilia Treatment Market Snippet by Treatment
2.1.3. Haemophilia Treatment Market Snippet by End Use
2.1.4. Haemophilia Treatment Market Snippet by Drug Therapy
2.1.5. Haemophilia Treatment Market Snippet by Country
2.1.6. Haemophilia Treatment Market Snippet by Region
2.2. Competitive Insights
3. Haemophilia Treatment Key Market Trends
3.1. Haemophilia Treatment Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Haemophilia Treatment Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Haemophilia Treatment Market Opportunities
3.4. Haemophilia Treatment Market Future Trends
4. Haemophilia Treatment Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Haemophilia Treatment Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Haemophilia Treatment Market Landscape
6.1. Haemophilia Treatment Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Haemophilia Treatment Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
7.1.2. Haemophilia A
7.1.3. Haemophilia B
8. Haemophilia Treatment Market – By Treatment
8.1. Overview
8.1.1. Segment Share Analysis, By Treatment, 2022 & 2030 (%)
8.1.2. Prophylaxis
8.1.3. On Demand
9. Haemophilia Treatment Market – By End Use
9.1. Overview
9.1.1. Segment Share Analysis, By End Use, 2022 & 2030 (%)
9.1.2. Hospitals
9.1.3. Clinics
9.1.4. Haemophilia Treatment Centers
10. Haemophilia Treatment Market – By Drug Therapy
10.1. Overview
10.1.1. Segment Share Analysis, By Treatment, 2022 & 2030 (%)
10.1.2. Recombinant coagulation factor concentrates therapy
10.1.3. Plasma derived coagulation factor concentrates therapy
10.1.4. Non-factor replacement therapy
10.1.5. Others
11. Haemophilia Treatment Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
11.2. North America
11.2.1. Overview
11.2.2. Haemophilia Treatment Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.2.5. North America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.2.6. North America Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.2.7. North America Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Haemophilia Treatment Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.3.6. Europe Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.3.7. Europe Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.9.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.9.4. Italy Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.3.9.5. Italy Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.3.9.6. Italy Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.10.4. United Kingdom Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.3.10.5. United Kingdom Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.3.10.6. United Kingdom Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.11.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.11.4. France Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.3.11.5. France Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.3.11.6. France Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.3.12. Russia
11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.12.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.12.3. Russia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.3.12.4. Russia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.3.12.5. Russia Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.3.13. Netherlands
11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.13.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.13.3. Netherlands Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.3.13.4. Netherlands Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.3.13.5. Netherlands Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.3.14. Sweden
11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.14.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.3.15. Poland
11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.15.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.15.3. Poland Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.3.15.4. Poland Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.3.15.5. Poland Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.3.16. Rest of Europe
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.16.4. Rest of the Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.3.16.5. Rest of the Europe Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.3.16.6. Rest of the Europe Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Haemophilia Treatment Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.5. Asia Pacific Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.4.6. Asia Pacific Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.4.7. Asia Pacific Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.8.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.8.4. India Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.4.8.5. India Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.4.8.6. India Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.9.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.9.4. China Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.4.9.5. China Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.4.9.6. China Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.4.13. Thailand
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.13.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.13.4. Thailand Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.4.13.5. Thailand Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.4.13.6. Thailand Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.4.14. Indonesia
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.14.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.14.4. Indonesia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.4.14.5. Indonesia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.4.14.6. Indonesia Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.5. Latin America
11.5.1. Overview
11.5.2. Haemophilia Treatment Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.5.5. Latin America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.5.6. Latin America Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.5.7. Latin America Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. Haemophilia Treatment Key Manufacturers in Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.6.5. Middle East and Africa Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.6.6. Middle East and Africa Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.6.7. Middle East and Africa Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By Drug Therapy, 2018 - 2030 (US$ Million)
12. Key Vendor Analysis- Haemophilia Treatment Industry
12.1. Competitive Dashboard
12.2. Company Profiles
12.2.1. Bayer Healthcare
12.2.2. Biogen
12.2.3. Biotest AG
12.2.4. CSL Behring
12.2.5. Ferring B.V.
12.2.6. Genentech
12.2.7. Kedrion
12.2.8. Novo Nordisk
12.2.9. Octapharma
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
